ADAP
Adaptimmune Therapeutics
ADAP
ADAP
56 hedge funds and large institutions have $216M invested in Adaptimmune Therapeutics in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 3 closing their positions.
Holders
56
Holders Change
+7
Holders Change %
+14.29%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
12
Reduced
13
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$2K